By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tioga Pharmaceuticals 

San Diego  California    U.S.A.
Phone: n/a Fax:



Company News
Tioga Pharmaceuticals Announces Initiation Of Phase 2 Clinical Study Of Asimadoline In Patients With Pruritus Associated With Atopic Dermatitis 6/11/2015 6:24:26 AM
Tioga Pharmaceuticals Raises $10 Million to Continue Phase III Development of IBS Drug 4/13/2012 7:29:14 AM
Tioga Pharmaceuticals Issued Key U.S. Patent for the Use of Asimadoline to Treat D-IBS 6/16/2011 7:19:53 AM
FDA Grants Fast Track Designation to Tioga Pharmaceuticals' Asimadoline for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome 6/1/2011 10:12:51 AM
Tioga Pharmaceuticals Begins Phase 3 Trial of Asimadoline in Irritable Bowel Syndrome 6/3/2010 8:33:17 AM
Tioga Pharmaceuticals Receives Special Protocol Assessment Agreement From FDA for Phase 3 Trials of Asimadoline in Irritable Bowel Syndrome 4/5/2010 10:58:37 AM
Tioga Pharmaceuticals Raises $18 Million to Fund Phase 3 Clinical Trial in Irritable Bowel Syndrome 2/17/2010 6:34:26 AM
Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome 5/21/2008 6:41:43 AM
Tioga Pharmaceuticals to Present Asimadoline Phase 2b Data in Irritable Bowel Syndrome at Digestive Disease Week 2008 Annual Meeting 5/15/2008 7:21:51 AM
New Leaf Venture Partners Announces $12 Million Financing In Tioga Pharmaceuticals 1/10/2006 10:56:47 AM